StockData
Ocean Biomedical, Inc. logo

Ocean Biomedical, Inc. (OCEA) stock

OCEAOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q1 FY2025, quarter ended Mar 31, 2025Last filing: 10-Q on May 15, 2025
$0.00−0.00 (-16.67%)

Close on Oct 19, 2026Market cap $45.51KP/E –Yield –

Ocean Biomedical statistics

23 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
–
Last ex-dividend date
No dividends
Fundamentals through
Mar 31, 2025
Share price as of
–

Share statisticsIndustry

Shares Change (QoQ)
376.1%
0.50%
Float
232M
49M
Shares Held by Insiders
0.00%
11.7%
Shares Held by Institutions
0.00%
56.4%

Returns on capitalIndustry

Return on Assets (ROA)
-1941.8%
-40.6%

Financial positionIndustry

Current Ratio
0.06
3.30
Quick Ratio
0.03
2.39

EfficiencyIndustry

Profits Per Employee
-$3.41M
-$689.41K
Employee Count
9
74

Income statement (TTM)Industry

Operating Income
-$4.16M
-$21.37M
Net Income
-$30.72M
-$22.35M
EBITDA
-$4.16M
-$17.21M
EPS (Diluted)
-$0.91
-$0.76

Balance sheetIndustry

Net Cash (Debt)
$800.00K
$17.76M
Net Cash Per Share
$0.00
$0.80
Equity (Book Value)
-$92.40M
$53.89M
Book Value Per Share
-$0.40
$1.50
Tangible Book Value
-$92.40M
$27.13M
Working Capital
-$25.08M
$79.99M

Cash flow (TTM)Industry

Operating Cash Flow
-$4.05M
-$12.38M

Scores and fair valueIndustry

Piotroski F-Score
2
4

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Oct 19, 2026. The S&P 500 is measured by the SPY fund.

PeriodOCEAS&P 500DifferenceOCEA per yearS&P 500 per year
1 month-44.4%+0.6%−45.1 pts
3 months+25.0%+3.4%+21.6 pts
Year to date0.0%+13.3%−13.3 pts
1 year-50.0%+16.6%−66.6 pts
3 years-100.0%+86.4%−186.4 pts-93.7%+23.1%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

0M OCEA shares were sold short on Oct 30, 2026, up 0.0% from the previous report. At recent volumes it would take 1.5 days to buy them back. Over the last 20 sessions, 53.6% of the volume reported to FINRA was short selling.

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 202665,4010.0%42,6661.5
Oct 15, 202665,4010.0%108,3011.0
Sep 30, 202665,4010.0%50,5241.3
Sep 15, 202665,401-0.0%86,0341.0
Aug 31, 202665,404-0.0%108,3701.0
Aug 14, 202665,4050.0%305,2381.0
Jul 31, 202665,4050.0%100,2141.0
Jul 15, 202665,4050.0%56,3041.2
Jun 30, 202665,405-1.5%93,0641.0
Jun 15, 202666,427-5.4%72,0371.0
May 29, 202670,234-0.1%118,8171.0
May 15, 202670,320+7.5%179,5381.0

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?